Bottom line
How has CURE performed?
As of Dec 31, 2025, CURE returned +22.9% over the past year, +8.6% a year over five years, +13.6% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $35,700. Its five-year return beat 81% of leveraged & inverse funds we track. Its best quarter was +46.9% and its worst −45.8%.
Updated Dec 31, 2025
CURE annual returns by year
| Year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| CURE | +22.9% | −8.5% | −9.8% | −20.4% | +87.4% | +5.1% | +55.9% | +2.9% | +69.3% | −17.4% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in CURE
$10,000 invested at the start of 2016 would have been worth about $35,700 by the end of 2025, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2025 | +22.9% | $35,677 |
| 2024 | −8.5% | $29,034 |
| 2023 | −9.8% | $31,735 |
| 2022 | −20.4% | $35,167 |
| 2021 | +87.4% | $44,163 |
| 2020 | +5.1% | $23,561 |
| 2019 | +55.9% | $22,414 |
| 2018 | +2.9% | $14,382 |
| 2017 | +69.3% | $13,975 |
| 2016 | −17.4% | $8,257 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| CURE | +22.9% | +8.6% | +13.6% | — |
| Leveraged & Inverse median | −7.7% | −11.8% | −13.5% | — |
Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending Jul 31, 2026, CURE returned +6.29%, +18.95%, +5.39% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.